Loading insider details...
Beta
Latest Form 4 (Oct 13, 2026): Grant/Award of 389 ANTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 389 | n/a |
| Sep 25, 2026 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Sale | 50,000 | $193.0K |
| Jul 10, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 766 | n/a |
| Jul 3, 2026 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/Award | 75,000 | n/a |
| Apr 11, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 1,192 | n/a |
| Mar 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 24,999 | n/a |
| Mar 17, 2026 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Exercise/Conversion | 74,700 | n/a |
| Feb 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 20,400 | n/a |
| Jan 14, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 3,650 | n/a |
| Dec 30, 2025 | CYPHERPUNK TECHNOLOGIES INC. (CYPH) | Grant/Award | 94,050 | n/a |